Focal Segmental News Today

Michelle Rheault, MD, provides additional perspective on the results of the DUPLEX trial, which examined sparsentan in patients with FSGS.

Although the DUPLEX trial missed its primary endpoint of eGFR slope in patients with FSGS, results point to greater reductions in proteinuria and in risk of kidney failure with sparsentan use relative to irbesartan—making its case for becoming a standard of care for the glomerular disease.

At least a dozen people, mainly low-income women, are being discriminated against by a community hospital, according to an immigrant advocacy group, which adds...

Nearly 4,700 people in Mass. are waiting for organs. Most need a kidney. Others on the list need a liver, a pancreas and even a heart.

Dimerix latest study offers hope for chronic obstructive pulmonary disease

Giselle Kennedy, 32, was told the devastating news that she had end-stage kidney failure in December 2019. Best friend Leah Philbin, 31, was first to offer her organ and medics were shocked to discover the pair were a perfect match - before joking they could even be sisters. The pair, from Nottingham, are now both recovering from the successful surgery which took place on May 26 this year. Giselle, who works in communications, said she could not be happier and praised her friends generosity fo...